Home > Healthcare > Medical Services > Surgical Services > Gynecomastia Procedures Market
Gynecomastia Procedures Market size was valued at USD 808.5 million in 2022 and is estimated to account for USD 1.8 billion by 2032. Gynecomastia procedures are medical treatments aimed at addressing the enlargement of male breast tissue, known as gynecomastia.
This condition can occur due to hormonal imbalances, certain medications, or underlying medical issues and can affect males of all ages, causing physical discomfort and emotional distress. The procedures aim to reduce or eliminate excess breast tissue and restore a more masculine chest appearance. The choice of treatment depends on the severity of the condition, the patient's age, overall health, and cosmetic goals. Moreover, growing awareness, surge in technological advancements, rising social acceptance, and improved healthcare infrastructure.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Gynecomastia Procedures Market Size in 2022: | USD 808.5 Million |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 8.1% |
2032 Value Projection: | USD 1.8 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 246 |
Tables, Charts & Figures: | 337 |
Segments covered: | Procedure Type, Age Group, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Obesity is closely linked to hormonal imbalances, particularly an increase in estrogen levels relative to testosterone. Excess adipose tissue in obese individuals can lead to higher estrogen production, contributing to the development of gynecomastia. The fat tissues can be excised through liposuction, surgical excision, and other procedures including lasers, radiofrequency, or ultrasound. For instance, according to the 2022 report from the World Health Organization (WHO), more than 1 billion people worldwide are affected by obesity, and this number is still increasing. Furthermore, by 2025, around 167 million individuals will experience health issues due to obesity.